Advertisements


A New FDA Approval Sends Small Cap Flexion Soaring

Flexion's non-opioid pain management drug has huge potential, and it's looking to expand into more indications......»»

Category: topSource: foxnewsOct 13th, 2017

A Generic Drug Face-Off Sends Mylan Soaring 19%

The surprising FDA approval of Mylan's generic version of Teva Pharmaceutical's top-selling multiple sclerosis drug Copaxone is sending shares higher today......»»

Category: topSource: foxnewsOct 4th, 2017

Early FDA Approval Speculation Sends AcelRX Pharma Shares Soaring

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) shares have been on a tear and are trading near a two-year high after speculation started doing the rounds that its pain treatment candidate DSUVIA is poised to get early approval. read more.....»»

Category: blogSource: benzingaOct 2nd, 2017

Positive Results For MDD Drug Sends Shares Of SAGE Therapeutics Inc (SAGE) Soaring

Shares of SAGE Therapeutics Inc (NASDAQ:SAGE) surged after the results of a small, mid-stage study on major depressive disorder showed posi.....»»

Category: topSource: insidermonkeyFeb 14th, 2017

Trumphoria Sends Small Business Optimism Soaring Most Since 1980

Since Donald Trump won the US election, small business optimism has exploded higher (from 94.9 in Oct to 105.8 in Dec). At the most optimistic since .....»»

Category: blogSource: zerohedgeJan 10th, 2017

Your Daily Pharma Scoop: Synergy"s Cash Position, Flexion"s Zilretta Approval, Keryx Major Catalyst

Your Daily Pharma Scoop: Synergy"s Cash Position, Flexion"s Zilretta Approval, Keryx Major Catalyst.....»»

Category: topSource: seekingalphaOct 10th, 2017

Flexion Therapeutics Just Hit A Major Milestone

Flexion Therapeutics Inc (NASDAQ: FLXN) announced last week it has received regulatory approval for its Zilretta therapy represents a "monumental milestone" for the company, BMO Capital Markets analyst Latest Ratings for FLXN DateFi.....»»

Category: blogSource: benzingaOct 9th, 2017

Flexion shares surge on FDA approval for its non-opioid knee pain medication

Making the company’s injection one of the few new non-opioid medications for pain......»»

Category: topSource: marketwatchOct 6th, 2017

Flexion shares surge 18% on news of FDA approval for non-opioid knee pain injection

Flexion Therapeutics Inc. shares surged 18% in afternoon trade Friday on news that the company's non-opioid injection for osteoarthritis knee pain has been approved by the Food a.....»»

Category: topSource: marketwatchOct 6th, 2017

Flexion shares halted on news of FDA approval for knee pain injection

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 6th, 2017

As Donald Trump"s Approval Rating Flounders, Possible Next President Mike Pence’s Is Soaring

Vice President Mike Pence has seen his favorability among voters rise, while his boss remains far from beloved......»»

Category: topSource: newsweekOct 4th, 2017

Patent Application Sends Cesca Therapeutics Shares Soaring

Cesca Therapeutics Inc (NASDAQ: KOOL) shares have moved out of a one-year trading range of $2.50–$4 Tuesday and are currently at their highest level in over a year. read more.....»»

Category: blogSource: benzingaOct 3rd, 2017

Las Vegas Shooting Sends Gun Stocks Soaring

Gun share prices rise after mass shootings with the perception that tighter gun control rules will follow and that people need to better protect themselves.....»»

Category: topSource: newsweekOct 2nd, 2017

Trump"s biggest shake-up of tax system sends dollar, bond yields soaring

The dollar's strength pressured many emerging market currencies and commodities.....»»

Category: topSource: business-standardSep 28th, 2017

Equifax"s Data Breach Sends Wake-Up Call to Small Business Owners

Data security should be one of your business's priorities......»»

Category: topSource: incSep 27th, 2017

Trump"s "Best Week Since Inauguration" Sends Approval Rating To 4-Month Highs

This was President Trump's best week since inauguration as his job appro.....»»

Category: blogSource: zerohedgeSep 22nd, 2017

Where did that bodega danish come from?

Humayun Kabir has been making his small patch of Carroll Gardens a better place for more than 20 years. Each night his bakery sends clouds of cinnamon into the air, delighting the neighborhood's... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkSep 11th, 2017

BoC Sends CAD Soaring With Shock Rate Hike

Does the BoC Have More Hikes in Store? The Bank of Canada unexpectedly raised interest rates on Wednesday by 25 basis points, triggering a sharp appreciation in the Canadian dollar and taking it to more than two-year lows aga.....»»

Category: topSource: marketpulseSep 6th, 2017

Donald Trump’s Approval Rating Is Far Lower Than Obama’s Was, but He’s Not the Least Popular President Ever

President Trump got a small bit of good news in the polls, but he’s more than a dozen percentage points behind where Obama was in 2009......»»

Category: topSource: newsweekSep 5th, 2017

Donald Trump"s Approval Rating Is Far Lower Than Obama"s Was, but He"s Not the Least Popular President Ever

President Trump got a small bit of good news in the polls, but he's more than a dozen percentage points behind where Obama was in 2009......»»

Category: topSource: newsweekSep 5th, 2017

Why Juno Therapeutics Shares Vaulted 46% Higher in August

Optimism is soaring following the FDA approval of Novartis' CAR-T and the $11.9 billion acquisition of CAR-T developer Kite Pharma......»»

Category: topSource: foxnewsSep 5th, 2017